What is the recommended treatment for a patient with skin‑picking disorder?

Treatment for Skin-Picking Disorder

Cognitive behavioral therapy with habit reversal training (HRT) should be the first-line treatment for skin-picking disorder, with N-acetylcysteine (NAC) as an adjunct or alternative when behavioral therapy is insufficient or unavailable 1, 2.

Treatment Algorithm

First-Line: Behavioral Interventions

Start with habit reversal therapy (HRT) combined with stimulus control techniques 1, 2, 3. This approach is effective across all severity levels and particularly beneficial when picking occurs with lowered awareness or is habitual in nature 2, 4.

Core HRT components include:

• Awareness training: Teaching patients to recognize triggers and early warning signs of picking urges
• Competing response training: Implementing alternative behaviors (e.g., making a fist, holding an object) when urges arise
• Stimulus control: Modifying environmental triggers that facilitate picking 4

The evidence strongly supports HRT, with recent systematic reviews demonstrating it as one of the most effective nonpharmacological treatments 1. Importantly, dermatologists can implement basic HRT techniques in their practice when patients decline psychiatric referral 3.

Augmentation for Emotion-Driven Picking

When picking is primarily triggered by negative emotions or distress, add acceptance and commitment therapy (ACT) or dialectical behavior therapy (DBT) techniques to augment HRT 2. ACT-enhanced group behavioral therapy has shown particularly strong results in recent trials 1. This is critical because emotion dysregulation is strongly associated with focused (intentional, affect-driven) picking 5.

Pharmacological Options

First-Line Pharmacotherapy: N-Acetylcysteine (NAC)

NAC should be considered for all severity levels given its moderate efficacy and favorable side effect profile 2. This glutamatergic agent has been well-established in SPD treatment 6.

Second-Line: SSRIs

Selective serotonin reuptake inhibitors (SSRIs) are the most promising pharmacological option and show the best results in mitigating severity and frequency of skin-picking symptoms 6. SSRIs are increasingly used in combination with psychotherapy and should be prioritized when:

• Behavioral therapy alone is insufficient
• Significant psychiatric comorbidities exist (depression, anxiety, OCD)
• Previous behavioral/NAC treatment has failed 2

Alternative Pharmacological Agents

Consider naltrexone (opioid antagonist) or antipsychotics (olanzapine, aripiprazole) as third-line options, though evidence is more limited 6. These may be particularly useful when combined with antidepressants in treatment-resistant cases.

Critical Diagnostic Distinction

Ensure the skin picking is NOT driven by appearance concerns before diagnosing skin-picking disorder 4. If picking is motivated by attempts to correct perceived appearance flaws, this indicates body dysmorphic disorder (BDD), which requires different treatment approaches. In BDD, the picking is intended to improve appearance of perceived skin defects, whereas in true SPD, picking occurs independent of appearance-related motivations 4.

Common Pitfalls

• Underestimating psychiatric comorbidities: Screen for personality disorders (19.2%), substance use disorders (16.8%), depression, and anxiety, as these are highly prevalent and influence treatment selection 7
• Inadequate follow-up: Only 41% of SPD patients receive appropriate medical follow-up 7. Establish regular reassessment schedules
• Premature biopsy: Only 11% of cases require biopsy 7. Reserve this for atypical presentations or when ruling out other dermatologic conditions
• Failing to address picking style: Automatic (low-awareness) picking responds better to HRT/stimulus control, while focused (emotion-driven) picking requires emotion regulation strategies 2, 5

Practical Implementation

For dermatologists managing SPD directly:

1. Implement basic HRT techniques during visits 3
2. Prescribe NAC as initial pharmacotherapy 2
3. Provide local wound care and supportive measures 7
4. Establish collaborative care with psychiatry when available

When to escalate to psychiatry:

• Severe psychiatric comorbidities
• Treatment-resistant cases
• Need for intensive CBT/ACT therapy
• Consideration of SSRI or other psychotropic medications requiring specialized monitoring

The evidence consistently demonstrates that combined behavioral and pharmacological approaches yield superior outcomes compared to either modality alone 6, 1, 2.